KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Recursion Pharmaceuticals (RXRX) Goodwill & Intangibles (2020 - 2025)

Recursion Pharmaceuticals' Goodwill & Intangibles history spans 6 years, with the latest figure at $472.1 million for Q4 2025.

  • For Q4 2025, Goodwill & Intangibles fell 2.61% year-over-year to $472.1 million; the TTM value through Dec 2025 reached $472.1 million, down 2.61%, while the annual FY2025 figure was $472.1 million, 2.61% down from the prior year.
  • Goodwill & Intangibles reached $472.1 million in Q4 2025 per RXRX's latest filing, down from $484.4 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $505.6 million in Q2 2025 to a low of $2.0 million in Q2 2022.
  • Average Goodwill & Intangibles over 5 years is $150.3 million, with a median of $85.6 million recorded in 2024.
  • Peak YoY movement for Goodwill & Intangibles: decreased 13.0% in 2022, then surged 4977.34% in 2023.
  • A 5-year view of Goodwill & Intangibles shows it stood at $2.2 million in 2021, then dropped by 3.61% to $2.1 million in 2022, then surged by 4100.24% to $88.5 million in 2023, then skyrocketed by 447.72% to $484.7 million in 2024, then fell by 2.61% to $472.1 million in 2025.
  • Per Business Quant, the three most recent readings for RXRX's Goodwill & Intangibles are $472.1 million (Q4 2025), $484.4 million (Q3 2025), and $505.6 million (Q2 2025).